Heart surgery sedative may shield the heart from damage
NCT ID NCT04871308
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether dexmedetomidine, a sedative that preserves breathing better than other drugs, can protect the heart during cardiac bypass surgery. Researchers measured heart damage in 224 adults undergoing heart surgery with a heart-lung machine. The goal was to see if this drug reduces injury and inflammation after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could continuing a common heart drug before surgery save lives?
- Could waking up in the operating room speed heart surgery recovery?
- Can a simple frailty check predict how well seniors recover from heart surgery?
- Could a simple scheduling change ease heart surgery nerves?
- Calcium timing during bypass may cut need for heart drugs
- Heart surgery recovery gets a wireless watchdog